Kerry Schaffer - Concepedia

Author

Kerry Schaffer

Vanderbilt University Medical Center ORCID

Also Known As

K SCHAFFER, K. Schaffer, Katherine Schaffer, Kerry R Schaffer, Kerry R. Schaffer, Kerry Roe Schaffer, Kerry Schaffer, Schaffer, Kerry

Publications

611

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center Vanderbilt University Levine Cancer Institute

About

Kerry Schaffer is an author at Vanderbilt University Medical Center specializing in molecular diagnostics, cancer research, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	37
2	Public Health	1	1	18
3	Biostatistics	1	1	18
4	Cell Biology	1	1	19
5	Epidemiology	1	1	18

Kerry Schaffer

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease Hong Yuen Wong, Quanhu Sheng, Amanda B. Hesterberg, Nature Communications	2022	104
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma Matthew D. Tucker, Landon C. Brown, Yu‐Wei Chen, Biomarker Research	2021	41
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin Catherine C. Fahey, Caroline A. Nebhan, Sally J. York, International Journal of Molecular Sciences	2023	21
A distinct repertoire of <scp>cancer‐associated</scp> fibroblasts is enriched in cribriform prostate cancer Amanda B. Hesterberg, Brenda Rios, Colby A. Tubbs, The Journal of Pathology Clinical Research PathologyCancer BiologyTumor BiologyGenitourinary CancerCancer Cell Biology	2021	19
A Polygenic Risk Score for Prostate Cancer Risk Prediction Kerry Schaffer, Mingjian Shi, John P. Shelley, JAMA Internal Medicine Polygenic RiskPrognosisGenetic EpidemiologyEpidemiology Of CancerCancer Registration	2023	18
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma Yu‐Wei Chen, Matthew D. Tucker, Landon C. Brown, Cancers	2022	17
C‐reactive protein is an independent prognostic marker in patients with tongue carcinoma ‐ A retrospective study Matthias Graupp, Kerry Schaffer, Axel Wolf, Clinical Otolaryngology	2018	14

Page 1